S
PMCB icon

Sachetta’s PharmaCyte Biotech PMCB Stock Holding History

Sachetta’s Portfolio PMCB Stock Details PMCB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11 Hold
14
– – ﹤0.01% 1021
2026
Q1 		$10 Hold
14
– – ﹤0.01% 1069
2025
Q4 		$11 Hold
14
– – ﹤0.01% 1024
2025
Q3 		$14 Hold
14
– – ﹤0.01% 1065
2025
Q2 		$16 Hold
14
– – ﹤0.01% 1090
2025
Q1 		$18 Hold
14
– – ﹤0.01% 1107
2024
Q4 		$22 Hold
14
– – ﹤0.01% 1182
2024
Q3 		$28 Hold
14
– – ﹤0.01% 1206
2024
Q2 		$28 Hold
14
– – ﹤0.01% 1227
2024
Q1 		$31 Hold
14
– – ﹤0.01% 1140
2023
Q4 		$31 Buy
+14
New +$30 ﹤0.01% 1140

Other funds holding PMCB

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Sachetta's PMCB Position: Q2 2026 in Review

Sachetta held its PharmaCyte Biotech (PMCB) position steady in Q2 2026 at 14 shares worth $11. The position accounts for ﹤0.01% of the portfolio, ranked #1021.

Sachetta first reported a position in PMCB in Q4 2023 and has held it in 11 quarters since. The position peaked at $31 in Q1 2024. 19 funds tracked by Wall St. Rank hold PMCB as of Q2 2026.

  • Sachetta held 14 shares of PharmaCyte Biotech worth $11 as of Q2 2026.
  • Sachetta left its PharmaCyte Biotech share count unchanged in Q2 2026.
  • PharmaCyte Biotech made up ﹤0.01% of Sachetta's portfolio in Q2 2026, its #1021 holding.
  • Sachetta first reported a position in PharmaCyte Biotech in Q4 2023 and has held it in 11 quarters since.
  • Sachetta's PharmaCyte Biotech position peaked at $31 in Q1 2024.
  • 19 funds tracked by Wall St. Rank held PharmaCyte Biotech as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.